Annual Long Term Debt
$85.84 M
+$3.54 M+4.30%
December 31, 2023
Summary
- As of February 26, 2025, TCRX annual long term debt is $85.84 million, with the most recent change of +$3.54 million (+4.30%) on December 31, 2023.
- During the last 3 years, TCRX annual long term debt has risen by +$79.82 million (+1326.15%).
- TCRX annual long term debt is now at all-time high.
Performance
TCRX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$86.46 M
+$9.34 M+12.10%
September 30, 2024
Summary
- As of February 26, 2025, TCRX quarterly long term debt is $86.46 million, with the most recent change of +$9.34 million (+12.10%) on September 30, 2024.
- Over the past year, TCRX quarterly long term debt has increased by +$4.96 million (+6.09%).
- TCRX quarterly long term debt is now at all-time high.
Performance
TCRX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
TCRX Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.3% | +6.1% |
| 3 y3 years | +1326.2% | +6.1% |
| 5 y5 years | +1831.6% | +6.1% |
TCRX Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1854.5% | at high | +2373.1% |
| 5 y | 5-year | at high | +1854.5% | at high | +2373.1% |
| alltime | all time | at high | +1854.5% | at high | +2373.1% |
TScan Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $86.46 M(+12.1%) |
| Jun 2024 | - | $77.12 M(-5.5%) |
| Mar 2024 | - | $81.63 M(-4.9%) |
| Dec 2023 | $85.84 M(+4.3%) | $85.84 M(+5.3%) |
| Sep 2023 | - | $81.50 M(-2.4%) |
| Jun 2023 | - | $83.53 M(+2.5%) |
| Mar 2023 | - | $81.48 M(-1.0%) |
| Dec 2022 | $82.30 M | $82.30 M(+156.4%) |
| Sep 2022 | - | $32.10 M(+818.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $3.50 M(-11.4%) |
| Mar 2022 | - | $3.95 M(-10.1%) |
| Dec 2021 | $4.39 M(-27.0%) | $4.39 M(-8.3%) |
| Sep 2021 | - | $4.79 M(-8.1%) |
| Jun 2021 | - | $5.21 M(-7.3%) |
| Mar 2021 | - | $5.62 M(-6.6%) |
| Dec 2020 | $6.02 M(+35.4%) | - |
| Dec 2020 | - | $6.02 M |
| Dec 2019 | $4.44 M | - |
FAQ
- What is TScan Therapeutics annual long term debt?
- What is the all time high annual long term debt for TScan Therapeutics?
- What is TScan Therapeutics annual long term debt year-on-year change?
- What is TScan Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for TScan Therapeutics?
- What is TScan Therapeutics quarterly long term debt year-on-year change?
What is TScan Therapeutics annual long term debt?
The current annual long term debt of TCRX is $85.84 M
What is the all time high annual long term debt for TScan Therapeutics?
TScan Therapeutics all-time high annual long term debt is $85.84 M
What is TScan Therapeutics annual long term debt year-on-year change?
Over the past year, TCRX annual long term debt has changed by +$3.54 M (+4.30%)
What is TScan Therapeutics quarterly long term debt?
The current quarterly long term debt of TCRX is $86.46 M
What is the all time high quarterly long term debt for TScan Therapeutics?
TScan Therapeutics all-time high quarterly long term debt is $86.46 M
What is TScan Therapeutics quarterly long term debt year-on-year change?
Over the past year, TCRX quarterly long term debt has changed by +$4.96 M (+6.09%)